Page last updated: 2024-08-16

resveratrol and Cirrhoses, Experimental Liver

resveratrol has been researched along with Cirrhoses, Experimental Liver in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, J; Ma, Z; Wu, S; Xu, M; Xue, W1
Hong, SS; Hong, SW; Jung, KH; Lee, DH; Lee, HS; Park, IS; Suh, JK; Zheng, HM1
Bosch, J; Di Pascoli, M; Diví, M; García-Pagán, JC; Gracia-Sancho, J; Rodríguez-Vilarrupla, A; Rosado, E; Vilaseca, M1
Chávez, E; Moreno, MG; Muriel, P; Reyes-Gordillo, K; Segovia, J; Shibayama, M; Tsutsumi, V; Vergara, P1
Benedetti, A; Bolognini, L; Casini, A; D'Ambrosio, L; Di Sario, A; Ferretti, G; Orlandi, F; Ridolfi, F; Salzano, R; Svegliati-Baroni, G1

Other Studies

5 other study(ies) available for resveratrol and Cirrhoses, Experimental Liver

ArticleYear
Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model.
    Oxidative medicine and cellular longevity, 2016, Volume: 2016

    Topics: Animals; Anticoagulants; Apoptosis; Blood Platelets; Enoxaparin; Fibrinolytic Agents; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Platelet Aggregation; Portal Vein; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Splenectomy; Stilbenes; Venous Thrombosis

2016
The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats.
    Archives of pharmacal research, 2010, Volume: 33, Issue:4

    Topics: Animals; Antioxidants; Biomarkers; Body Weight; Dimethylnitrosamine; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Organ Size; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2010
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Journal of hepatology, 2013, Volume: 58, Issue:5

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Nitric Oxide Synthase Type III; Portal Pressure; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thromboxane A2

2013
Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats.
    Journal of applied toxicology : JAT, 2008, Volume: 28, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Carbon Tetrachloride; Glutathione; Glutathione Disulfide; Glycogen; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; NF-kappa B; Protective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Transforming Growth Factor beta

2008
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells.
    Journal of hepatology, 1999, Volume: 30, Issue:5

    Topics: Animals; Antioxidants; Carcinogens; Cell Cycle; Cell Division; Cells, Cultured; Collagen; Culture Media; Ferric Compounds; Fluoresceins; Fluorescent Dyes; Kinetics; Liver; Liver Cirrhosis, Experimental; Malondialdehyde; Nitrilotriacetic Acid; Oxidative Stress; Rats; Resveratrol; Sodium-Hydrogen Exchangers; Stilbenes; Thiobarbituric Acid Reactive Substances

1999